These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
455 related items for PubMed ID: 33019909
21. The inpatient costs related to revascularization of lower extremity artery disease in terms of amputation and mortality rates. Alptekin GS, Erkul S, Akgul E, Cekirdekci A. Vascular; 2024 Jun; 32(3):653-660. PubMed ID: 36749662 [Abstract] [Full Text] [Related]
22. Association Between Diagnosis-to-Limb Revascularization Time and Clinical Outcomes in Outpatients With Chronic Limb-Threatening Ischemia: Insights From the CLIPPER Cohort. Fanaroff AC, Dayoub EJ, Yang L, Schultz K, Ramadan OI, Wang GJ, Damrauer SM, Genovese EA, Secemsky EA, Parikh SA, Nathan AS, Kohi MP, Weinberg MD, Jaff MR, Groeneveld PW, Giri JS. J Am Heart Assoc; 2024 May 07; 13(9):e033898. PubMed ID: 38639376 [Abstract] [Full Text] [Related]
23. Nationally Representative Readmission Factors in Patients with Claudication and Critical Limb Ischemia. Martinez RA, Shnayder M, Parreco J, Gaffney L, Eby M, Cortolillo N, Lopez M, Zeltzer J. Ann Vasc Surg; 2018 Oct 07; 52():96-107. PubMed ID: 29777842 [Abstract] [Full Text] [Related]
24. Higher Inpatient Mortality for Women after Intervention for Lifestyle Limiting Claudication. Miller SM, Sumpio BJ, Miller MS, Erben Y, Cordova AC, Sumpio BE. Ann Vasc Surg; 2019 Jul 07; 58():54-62. PubMed ID: 30910650 [Abstract] [Full Text] [Related]
25. Impact of dual antiplatelet therapy after lower extremity revascularization for chronic limb-threatening ischemia. Ramanan B, Jeon-Slaughter H, Chen X, Kashyap VS, Kirkwood ML, Timaran CH, Modrall JG, Tsai S. J Vasc Surg; 2021 Oct 07; 74(4):1327-1334. PubMed ID: 34023428 [Abstract] [Full Text] [Related]
26. Epidemiology, treatment, and outcomes of acute limb ischemia in the pediatric population. Lim S, Javorski MJ, Halandras PM, Kuo PC, Aulivola B, Crisostomo P. J Vasc Surg; 2018 Jul 07; 68(1):182-188. PubMed ID: 29502995 [Abstract] [Full Text] [Related]
27. Lower Limb Revascularization for Peripheral Arterial Disease in 10,951 Procedures over 11 years in a Public Health System: A Descriptive Analysis of the Largest Brazilian City. Wolosker N, da Silva MFA, Leiderman DBD, Stabellini N, Nogueira WA, Szlejf C, Amaro E, Teivelis MP. Ann Vasc Surg; 2021 Jan 07; 70():223-229. PubMed ID: 32781262 [Abstract] [Full Text] [Related]
29. The Contemporary Safety and Effectiveness of Lower Extremity Bypass Surgery and Peripheral Endovascular Interventions in the Treatment of Symptomatic Peripheral Arterial Disease. Tsai TT, Rehring TF, Rogers RK, Shetterly SM, Wagner NM, Gupta R, Jazaeri O, Hedayati N, Jones WS, Patel MR, Ho PM, Go AS, Magid DJ. Circulation; 2015 Nov 24; 132(21):1999-2011. PubMed ID: 26362632 [Abstract] [Full Text] [Related]
30. Comparison of the Cost of Drug-Eluting Stents versus Bare Metal Stents in the Treatment of Critical Limb Ischemia in the United States. Locham SS, Paracha N, Dakour-Aridi H, Nejim B, Rizwan M, Malas MB. Ann Vasc Surg; 2019 Feb 24; 55():55-62.e2. PubMed ID: 30092444 [Abstract] [Full Text] [Related]
31. Chronic kidney disease and outcomes of lower extremity revascularization for peripheral artery disease. Smilowitz NR, Bhandari N, Berger JS. Atherosclerosis; 2020 Mar 24; 297():149-156. PubMed ID: 31948675 [Abstract] [Full Text] [Related]
32. Hypercoagulability predicts worse outcomes in young patients undergoing lower extremity revascularization. Torrealba JI, Osman M, Kelso R. J Vasc Surg; 2019 Jul 24; 70(1):175-180. PubMed ID: 30583891 [Abstract] [Full Text] [Related]
34. National trends of hybrid lower extremity revascularization in the ACS-NSQIP database. Fereydooni A, Zhou B, Jorshery SD, Deng Y, Dardik A, Chaar CIO. Vascular; 2019 Dec 24; 27(6):653-662. PubMed ID: 31126228 [No Abstract] [Full Text] [Related]
35. Temporal trends and outcomes of patients with chronic limb-threatening ischemia with and without history of coronary artery disease: insights from the us national inpatient sample database. Chunawala ZS, Chew C, Hendrickson M, Arora S, Tafur A, Mishkel G, Ricciardi MJ, Zelniker TA, Moussa ID, Hassan A, Golzar J, Gueyikian S, Bechara CF, Lee CJ, Qamar A. J Invasive Cardiol; 2023 Oct 24; 35(10):. PubMed ID: 37984325 [Abstract] [Full Text] [Related]
36. An analysis of the outcomes of a decade of experience with lower extremity revascularization including limb salvage, lengths of stay, and safety. Egorova NN, Guillerme S, Gelijns A, Morrissey N, Dayal R, McKinsey JF, Nowygrod R. J Vasc Surg; 2010 Apr 24; 51(4):878-85, 885.e1. PubMed ID: 20045618 [Abstract] [Full Text] [Related]
39. In-patient characteristics of peripheral artery disease in Germany. Block A, Köppe J, Feld J, Kühnemund L, Engelbertz C, Makowski L, Malyar N, Gerß J, Reinecke H, Freisinger E. Vasa; 2024 Jan 24; 53(1):28-38. PubMed ID: 37964740 [Abstract] [Full Text] [Related]
40. A Unique All-Payer Rate-Setting System Controls the Cost but Not the Racial Disparity in Lower Extremity Revascularization Procedures. Nejim B, Beaulieu RJ, Alshaikh H, Hamouda M, Canner J, Malas MB. Ann Vasc Surg; 2018 Oct 24; 52():116-125. PubMed ID: 29783031 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]